Vaxcyte shareholders re-elect all three Class II directors and approve officer exculpation

Vaxcyte, Inc.

John Furey reelected with 120.7M For vs 0.4M Withheld; Jacks Lee 107.3M For vs 13.8M Withheld.
Heath Lukatch, Ph.D. reelected with 99.2M For vs 21.9M Withheld.
Deloitte & Touche ratified as auditor for FY2025 with 124.8M For, 0.2M Against.
Advisory say-on-pay passed with 77.1M For, 44.0M Against, 4.0M broker non-votes.
Amendment to certificate for officer exculpation approved with 112.3M For, 8.8M Against.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.